Crossmark

Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1α transcription factors

Published Online: 2016-09-16

Authors

Miraglia, Erica

Nylén, Frank

Johansson, Katarina

Arnér, Elias

Cebula, Marcus

Farmand, Susan

Ottosson, Håkan

Strömberg, Roger

Gudmundsson, Gudmundur H.

Agerberth, Birgitta

Bergman, Peter
License Information

Text and Data Mining valid from 2016-09-16

Version of Record valid from 2016-09-16
More Information

Article History

Received: 20 April 2016

Accepted: 24 August 2016

First Online: 16 September 2016

Competing interests

: R.S., G.H.G., B.A. are co-founders of Akthelia, a company that holds a patent for the use of Entinostat in the treatment of infections; (Strömberg R., Ottoson H., Agerberth B., Gudmundsson G., Miraglia E. & Nylen F. Antimicrobial compounds. Application: WO patent 2014-IB65678 2015063694, 2015).

Document is current